Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Guerra

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Breast Cancer : Basic and Clinical Research|October 12, 2012
NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical TrialAna de la Torre, Julio Hernandez, Ramón Ortiz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2013
Structural insights into the Ca2+ and PI(4,5)P2 binding modes of the C2 domains of rabphilin 3A and synaptotagmin 1Jaime Guillén, Cristina Ferrer-Orta, Mònica Buxaderas, et al.
Frontiers in Physiology|February 27, 2023
Characterization of muscle mass, strength and mobility of critically ill patients with SARS-CoV-2 pneumonia: Distribution by sex, age, days on mechanical ventilation, and muscle weaknessAlexis Silva-Gutiérrez, Macarena Artigas-Arias, Andrea Alegría-Molina, et al.
Nature Communications|December 16, 2025
Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesionsDavid Vizarraga, Marina Marcos, Noemi Rotllan, et al.
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.
Lancet Regional Health. Americas|September 20, 2021
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trialArturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Breast Cancer : Basic and Clinical Research|October 12, 2012
NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical TrialAna de la Torre, Julio Hernandez, Ramón Ortiz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2013
Structural insights into the Ca2+ and PI(4,5)P2 binding modes of the C2 domains of rabphilin 3A and synaptotagmin 1Jaime Guillén, Cristina Ferrer-Orta, Mònica Buxaderas, et al.
Frontiers in Physiology|February 27, 2023
Characterization of muscle mass, strength and mobility of critically ill patients with SARS-CoV-2 pneumonia: Distribution by sex, age, days on mechanical ventilation, and muscle weaknessAlexis Silva-Gutiérrez, Macarena Artigas-Arias, Andrea Alegría-Molina, et al.
Nature Communications|December 16, 2025
Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesionsDavid Vizarraga, Marina Marcos, Noemi Rotllan, et al.
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.
Lancet Regional Health. Americas|September 20, 2021
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trialArturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, et al.
Pageof 3